UNLV scientists successfully introduced nanoparticles with messenger RNA into the pancreas for the first time with 99% ...

Scientists from CNRS have developed new stable and effective messenger RNA (mRNA) sequences that enable cells to produce therapeutic proteins themselves, capable of inducing antibody ...

Results of new research showing that COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients and prolonged ...

Arcturus Therapeutics (NASDAQ:ARCT) traded lower on Friday after Citi downgraded the San Diego, California-based biotech, citing mid-stage data the company posted this week for ARCT-032, a messenger ...

COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are ...

RNA-based COVID vaccines may enhance the immune response to certain cancer treatments. Advanced lung and skin cancer patients ...

New research shows Moderna and Pfizer’s mRNA vaccines may prime the immune system to attack cancer—even better than some ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

Historically, RSV has been associated with infants, but they are not the only group that can be affected by serious RSV ...

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

This finding, in conjunction with the University of Texas MD Anderson Cancer Center, comes as the DeSantis administration ...

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...